Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV-HCV”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02738138
What this trial is testing

Evaluate the Efficacy and Safety of Experimental Drugs ABT- 493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1-6 Infection and Human Immunodeficiency Virus -1 Coinfection (EXPEDITION-2)

Who this might be right for
Hepatitis C Virus InfectionHuman Immunodeficiency Virus InfectionChronic Hepatitis C+1 more
AbbVie 153
Large-scale testing (Phase 3)Study completedNCT01783678
What this trial is testing

A Phase 3, Open-label Study to Investigate the Efficacy and Safety of Sofosbuvir Plus Ribavirin in Chronic Genotype 1, 2, 3 and 4 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-infected Adults

Who this might be right for
Chronic Hepatitis CHuman Immunodeficiency Virus
Gilead Sciences 275
Not applicableStudy completedNCT01790633
What this trial is testing

Pilot Study Evaluating the Use of Simultaneous HBV, HCV, and HIV Rapid Tests

Who this might be right for
HIVHepatitis BHepatitis C+2 more
Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba 327
Large-scale testing (Phase 3)Study completedNCT01482767
What this trial is testing

Evaluating the Effectiveness of Boceprevir, Pegylated-Interferon Alfa 2b and Ribavirin in Treating Hepatitis C Virus (HCV) Infection in Adults With HIV and HCV Infection

Who this might be right for
HIV InfectionsHepatitis C
National Institute of Allergy and Infectious Diseases (NIAID) 262
Not applicableStudy completedNCT04366492
What this trial is testing

HBV/HCV/HIV in Belgian Prisons

Who this might be right for
Hepatitis CHepatitis BHIV Infections
Hasselt University 3,045
Not applicableStudy completedNCT03652675
What this trial is testing

Understanding and Intervening With Heavy Drinking Among Patients With HIV and HCV

Who this might be right for
Alcohol Use DisorderHIV/AIDSHepatitis C+1 more
New York State Psychiatric Institute 31
Post-approval studies (Phase 4)Not Yet RecruitingNCT07560046
What this trial is testing

Combating Related Epidemics in HCV

Who this might be right for
HIV - Human Immunodeficiency VirusHepatitis B Virus (HBV)HEPATITIS C (HCV)
Duke University 1,280
Not applicableLooking for participantsNCT05361603
What this trial is testing

Acceptability of Simultaneous Screening for Viral Hepatitis B, C and HIV Among Drug Users in Non-conventional Structures

Who this might be right for
Hepatitis CTransmission, Intravenous Drug AbuserAddiction, Alcohol+2 more
University Hospital, Limoges 1,500
Not applicableWithdrawnNCT00023218
What this trial is testing

Effect of a Change in HIV Therapy on Liver Steatosis, Inflammation, and Fibrosis

Who this might be right for
HIV InfectionsHepatitis C
National Institute of Allergy and Infectious Diseases (NIAID)
Large-scale testing (Phase 3)Study completedNCT01471574
What this trial is testing

Safety and Efficacy Study of Daclatasvir (BMS-790052) Plus Pegylated Interferon-Alfa 2a and Ribavirin in Patients Coinfected With Untreated Hepatitis C Virus and HIV Virus

Who this might be right for
Hepatitis C, Genotype 1
Bristol-Myers Squibb 549
Post-approval studies (Phase 4)Ended earlyNCT03221582
What this trial is testing

Impact of Hepatitis C Therapy and Bone Health

Who this might be right for
Human Immunodeficiency VirusHepatitis C
Dallas VA Medical Center 6
Not applicableUnknownNCT01273142
What this trial is testing

Compare to the Safety of Efavirenz and Nevirapine in Treating HIV Positive Patients With Mild Baseline Liver Function Test Impairment, and/or Hepatitis B or Hepatitis C Co-infection

Who this might be right for
HIV InfectionsLiver ToxicityHepatitis Co-infection
Henan Provincial People's Hospital 100
Not applicableStudy completedNCT04600479
What this trial is testing

Study on the Prevalence of Hepatitis C In a psychiatRic Population

Who this might be right for
Hepatitis C
Nantes University Hospital 796
Not applicableUnknownNCT02057003
What this trial is testing

Real-life Security and Efficacy of DAA-based Therapy in HCV/HIV-Coinfected Patients

Who this might be right for
Hepatitis C, ChronicHuman Immunodeficiency Virus
Valme University Hospital 1,000
Not applicableStudy completedNCT03324633
What this trial is testing

Inter Cohorts and Clinical Centres Collaborations of Subjects Co-infected With HIV and HCV

Who this might be right for
HIVHepatitis C
ANRS, Emerging Infectious Diseases 1,850
Early research (Phase 1)Study completedNCT02568332
What this trial is testing

Assess the Safety of Hep C Vaccine Candidates in HIV Seropositive Individuals

Who this might be right for
Hepatitis C Infection
University of Oxford 20
Not applicableWithdrawnNCT03158857
What this trial is testing

Hepatitis C Treatment Study in Myanmar

Who this might be right for
Hepatitis C
Myanmar Oxford Clinical Research Unit
Early research (Phase 1)Study completedNCT04688034
What this trial is testing

Safety and Tolerability Study of OP-724 in Liver Cirrhosis Patients by HIV/HCV with Hemophilia.

Who this might be right for
Liver Cirrhosis
Kiminori Kimura, MD 5
Not applicableStudy completedNCT05270135
What this trial is testing

ASAP: Access to Syringes at Pharmacies for the Prevention of Bloodborne Infections Among People Who Inject Drugs

Who this might be right for
Skin and Soft Tissue InfectionsHivHepatitis C+1 more
University of Arizona 18
Large-scale testing (Phase 3)Study completedNCT02707601
What this trial is testing

Efficacy, Safety, and Tolerability of Ledipasvir/Sofosbuvir (LDV/SOF) Treatment for HIV/HCV Co-infected Participants Who Switch to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) or Emtricitabine/Rilpivirine/Tenofovir Alafenamide (F/R/TAF) Prior to LDV/SOF HCV Treatment

Who this might be right for
HIV-1 InfectionHCV Infection
Gilead Sciences 150
Next Page